Literature DB >> 6227561

Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.

T Iwasaka, J F Sheridan, L Aurelian.   

Abstract

Cell-mediated immunity to herpes simplex virus type 2 was investigated in infected inbred strain 13/N guinea pigs with (45%), and without, a history of recurrent herpetic disease (A. D. Donnenberg, E. Chaikof, and L. Aurelian, Infect. Immun. 30:99-109, 1980). Induction of suppressor cells capable of reducing the proliferative response of herpes simplex virus type 2-stimulated immune lymphoid cells was demonstrated in spleen cells from animals with a history of recurrent disease at recrudescence and convalescence but not in spleen cells from quiescent animals or from animals without a history of recurrent herpetic disease (seropositive controls). Suppressor cells were also detected in the peripheral blood but only from three of seven studied animals, and only at recrudescence. In addition to inhibitory cell-cell interactions, the herpes simplex virus type 2-activated regulatory cells of animals with recrudescent herpetic lesions elaborated soluble suppressor factors affecting lymphocyte proliferation. Suppression mediated by suppressor factors was observed only when suppressor factors were added at an early stage of in vitro culture and was reversed by medium exchange throughout the 6 days of culture. Sephadex chromatography revealed the presence of factors capable of differentially modulating the proliferative response of herpes simplex virus-stimulated immune cells and concanavalin A-stimulated normal lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6227561      PMCID: PMC264392          DOI: 10.1128/iai.42.3.955-964.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  The suppressive effect of a supernate from concanavalin A-activated human lymphocytes: effects of concanavalin A-activated lymphocytes and their supernates on cytotoxic and mixed lymphocyte reactions.

Authors:  D B Kaufman; C Carnaud; J L Stach; J F Bach
Journal:  Cell Immunol       Date:  1979-09-15       Impact factor: 4.868

2.  Studies of human lymphocyte interactions with emphasis on soluble suppressor activity.

Authors:  R C Williams; S J Korsmeyer
Journal:  Clin Immunol Immunopathol       Date:  1978-03

3.  Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections.

Authors:  R B Bell; L Aurelian; G H Cohen
Journal:  Cell Immunol       Date:  1978-11       Impact factor: 4.868

4.  Mechanism of suppression of lymphocyte proliferation by Concanavalin A-activated mononuclear cells.

Authors:  R Lomnitzer; A R Rabson
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

5.  Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.

Authors:  W C Greene; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

6.  Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection.

Authors:  R P Jacobs; L Aurelian; G A Cole
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

7.  Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.

Authors:  A D Donnenberg; R B Bell; L Aurelian
Journal:  Cell Immunol       Date:  1980-12       Impact factor: 4.868

8.  Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.

Authors:  A D Donnenberg; E Chaikof; L Aurelian
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  A human soluble suppressor factor affecting lymphocyte responses in vitro.

Authors:  L Shou; S A Schwartz; R A Good; R Peng; C L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Suggestive evidence for both stimulatory and inhibitory domains on human lymphocytes, as indicated by phospholipid turnover studies with wheat germ agglutinin and other lectins.

Authors:  C W Parker; R E Dankner; S F Falkenhein; W C Greene
Journal:  Immunol Commun       Date:  1976
View more
  13 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

2.  Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection.

Authors:  C G Bridges; N Edington
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections.

Authors:  J A Carr; J Rogerson; M J Mulqueen; N A Roberts; R F Booth
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Production of soluble suppressor factors by herpes simplex virus-stimulated splenocytes from herpes simplex virus-immune mice.

Authors:  D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

5.  Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells.

Authors:  D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  Regulation of herpes simplex virus-specific cell-mediated immunity by a specific suppressor factor.

Authors:  D W Horohov; J H Wyckoff; R N Moore; B T Rouse
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 7.  Recurrent genital tract infection: a result of induced immunosuppression?

Authors:  C Sonnex
Journal:  Genitourin Med       Date:  1989-12

8.  Reduction of the number of immunocompetent cells in the acute stage of herpes zoster.

Authors:  O Baadsgaard; R Lindskov; C Geisler
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

9.  Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.

Authors:  J F Sheridan; L Aurelian; A D Donnenberg; T C Quinn
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

10.  In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model.

Authors:  J I Sin; J J Kim; J D Boyer; R B Ciccarelli; T J Higgins; D B Weiner
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.